Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1 15Phase 1/2 9Phase 3 4

Status

Active not recruiting 2Terminated 1Completed 1

Sponsor Class

INDUSTRY 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Triple Negative Breast Neoplasms 8Breast Neoplasms 8Parkinson Disease 4, Autosomal Dominant Lewy Body 7Neoplasms 5Neoplasm Metastasis 4Lung Neoplasms 4Adenocarcinoma 3Stomach Neoplasms 2Pancreatic Diseases 2Neoplasms by Site 2Endocrine System Diseases 2Endocrine Gland Neoplasms 2Digestive System Neoplasms 2Digestive System Diseases 2Carcinoma, Pancreatic Ductal 2Carcinoma, Ductal, Breast 2Carcinoma 2Uterine Cervical Neoplasms 1Squamous Cell Non-small Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Pericardial Effusion 1Pancreatic Cancer Non-resectable 1Pancreatic Adenocarcinoma 1Non-Small-Cell Lung 1Non Small Cell Lung Cancer NSCLC 1Neuralgia 1Neoplasms, Unknown Primary 1

Interventions

Leucovorin 22Fluorouracil 22Paclitaxel 21Gemcitabine 21Docetaxel 21Capecitabine 21Irinotecan 16Carboplatin 15Radiosurgery 14Oxaliplatin 13Cisplatin 13Bevacizumab 13Zoledronic Acid 12pembrolizumab 11Radiotherapy 11Fulvestrant 11palbociclib 9Pemetrexed 9Drug Therapy 9130-nm albumin-bound paclitaxel 9Surgical Procedures, Operative 7Letrozole 7Ibandronic Acid 7abemaciclib 6Trastuzumab 6Prednisone 6Vinorelbine 5Folfox protocol 5Floxuridine 5Doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Neoplasm Metastasis × Albumin-Bound Paclitaxel × Clear all
NCT04895358 2026-03-11

KEYNOTE-B49

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
340 enrolled
Breast

Parkinson Disease 4, Autosomal Dominant Lewy Body, Breast Neoplasms, Neoplasm Metastasis

NCT04879368 2025-07-17

INTEGRATEIIb

Australasian Gastro-Intestinal Trials Group

Phase 3 Active not recruiting
450 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT02715804 2020-07-14

A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma

Halozyme Therapeutics

Phase 3 Terminated
492 enrolled 16 charts
Gastrointestinal

Neoplasm Metastasis, Carcinoma, Pancreatic Ductal

NCT00046527 2006-07-13

Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer

Celgene Corporation

Phase 3 Completed
460 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡